Cargando…
Analytical validation of GMEX rapid point-of-care CYP2C19 genotyping system for the CHANCE-2 trial
BACKGROUND AND PURPOSE: Rapid genotyping is useful for guiding early antiplatelet therapy in patients with high-risk nondisabling ischaemic cerebrovascular events (HR-NICE). Conventional genetic testing methods used in CYP2C19 genotype-guided antiplatelet therapy for patients with HR-NICE did not sa...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258065/ https://www.ncbi.nlm.nih.gov/pubmed/33952669 http://dx.doi.org/10.1136/svn-2021-000874 |